Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2004-4-9
pubmed:abstractText
We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AG 1879, http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Caspases, http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/E2F Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/E2F1 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/E2F1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/E2f1 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleoside Diphosphate Reductase, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine, http://linkedlifedata.com/resource/pubmed/chemical/ribonucleotide reductase M2, http://linkedlifedata.com/resource/pubmed/chemical/src-Family Kinases
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2307-18
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15073106-Adenocarcinoma, pubmed-meshheading:15073106-Animals, pubmed-meshheading:15073106-Antimetabolites, Antineoplastic, pubmed-meshheading:15073106-Antineoplastic Agents, pubmed-meshheading:15073106-Apoptosis, pubmed-meshheading:15073106-Blotting, Northern, pubmed-meshheading:15073106-Blotting, Western, pubmed-meshheading:15073106-Caspases, pubmed-meshheading:15073106-Cell Cycle Proteins, pubmed-meshheading:15073106-Cell Division, pubmed-meshheading:15073106-Cell Line, Tumor, pubmed-meshheading:15073106-Cell Nucleus, pubmed-meshheading:15073106-DNA-Binding Proteins, pubmed-meshheading:15073106-Deoxycytidine, pubmed-meshheading:15073106-Dose-Response Relationship, Drug, pubmed-meshheading:15073106-Drug Resistance, Neoplasm, pubmed-meshheading:15073106-E2F Transcription Factors, pubmed-meshheading:15073106-E2F1 Transcription Factor, pubmed-meshheading:15073106-Genes, Dominant, pubmed-meshheading:15073106-Humans, pubmed-meshheading:15073106-Inhibitory Concentration 50, pubmed-meshheading:15073106-Mice, pubmed-meshheading:15073106-Mice, Nude, pubmed-meshheading:15073106-Neoplasm Metastasis, pubmed-meshheading:15073106-Neoplasm Transplantation, pubmed-meshheading:15073106-Pancreatic Neoplasms, pubmed-meshheading:15073106-Phosphorylation, pubmed-meshheading:15073106-Pyrimidines, pubmed-meshheading:15073106-Ribonucleoside Diphosphate Reductase, pubmed-meshheading:15073106-Transcription Factors, pubmed-meshheading:15073106-Tyrosine, pubmed-meshheading:15073106-src-Family Kinases
pubmed:year
2004
pubmed:articleTitle
Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
pubmed:affiliation
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't